1. Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody
   Mehmet Akce et al, 2021, American Journal of Clinical Oncology CrossRef
2. Fat-free muscle area measured by magnetic resonance imaging predicts overall survival of patients undergoing radioembolization of colorectal cancer liver metastases
   Anton Faron et al, 2019, European Radiology CrossRef
3. Calculated body muscle mass as a useful screening marker for low skeletal muscle mass and sarcopenia in chronic liver disease
   Tatsuki Ichikawa et al, 2020, Hepatology Research CrossRef
4. Radiological psoas muscle parameters as a reliable tool for detection of sarcopenia and prediction of short-term survival in liver cirrhosis
   V. M. Motsiuk et al, 2022, Reports of Morphology CrossRef
5. What Is the Role of Body Composition Assessment in HCC Management?
   Pompilia Radu et al, 2022, Cancers CrossRef
6. Sarcopenia Worsening One Month after Transarterial Radioembolization Predicts Progressive Disease in Patients with Advanced Hepatocellular Carcinoma
   Giulio Eugenio Vallati et al, 2021, Biology CrossRef
7. Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment
   Giulio Antonelli et al, 2018, United European Gastroenterology Journal CrossRef
8. Skeletal muscle mass is associated with toxicity, treatment tolerability, and additional or subsequent therapies in patients with hepatocellular carcinoma receiving sorafenib treatment
   Koji Sawada et al, 2019, JGH Open CrossRef
9. Psoas Muscle Index: A Simple and Reliable Method of Sarcopenia Assessment on Computed Tomography Scan in Chronic Liver Disease and its Impact on Mortality
   Gajanan A. Rodge et al, 2023, Journal of Clinical and Experimental Hepatology CrossRef
10. Skeletal muscle volume loss during transarterial chemoembolization predicts poor prognosis in patients with hepatocellular carcinoma
    Masashi Fujita et al, 2019, Hepatology Research CrossRef
11. Radiological Assessment of Sarcopenia and Its Clinical Impact in Patients with Hepatobiliary, Pancreatic, and Gastrointestinal Diseases: A Comprehensive Review
    Shameema Farook et al, 2024, Journal of Gastrointestinal and Abdominal Radiology CrossRef
12. Clinical impact of sarcopenia assessment in patients with liver cirrhosis
    Giovanni Marasco et al, 2021, Expert Review of Gastroenterology & Hepatology CrossRef
13. Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis
    Masashi Fujita et al, 2020, Medicine CrossRef
14. Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease
    Tatsuki Ichikawa et al, 2020, Biomedical Reports CrossRef
15. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments
    Giovanni Marasco et al, 2020, Journal of Gastroenterology CrossRef
16. Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
    Maurizio Biselli et al, 2024, Cancers CrossRef
17. Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
    Abhilash Perisetti et al, 2022, World Journal of Gastroenterology CrossRef
18. The Deterioration of Sarcopenia Post-Transarterial Radioembolization with Holmium-166 Serves as a Predictor for Disease Progression at 3 Months in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study
    Claudio Trobiani et al, 2024, Journal of Personalized Medicine CrossRef
19. Automated Measurements of Muscle Mass Using Deep Learning Can Predict Clinical Outcomes in Patients With Liver Disease
    Nicholas C. Wang et al, 2020, American Journal of Gastroenterology CrossRef
20. Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan
    Masashi Fujita et al, 2022, Scientific Reports CrossRef
21. Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature
    Maria Guarino et al, 2022, Digestive and Liver Disease CrossRef
22. Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma
    Chih-Horng Wu et al, 2021, Journal of the Formosan Medical Association CrossRef
23. Clinical Significance of Sarcopenia in Patients with Advanced Hepatocellular Carcinoma Undergoing Sorafenib Treatment
    Min-Hyuk Lee et al, 2021, Annals of Clinical Nutrition and Metabolism CrossRef